These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27399144)

  • 1. Impact of pay-for-performance on mortality in diabetes patients in Taiwan: A population-based study.
    Chen YC; Lee CT; Lin BJ; Chang YY; Shi HY
    Medicine (Baltimore); 2016 Jul; 95(27):e4197. PubMed ID: 27399144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes pay-for-performance program can reduce all-cause mortality in patients with newly diagnosed type 2 diabetes mellitus.
    Kung FP; Tsai CF; Lu CL; Huang LC; Lu CH
    Medicine (Baltimore); 2020 Feb; 99(7):e19139. PubMed ID: 32049836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A diabetes pay-for-performance program and the competing causes of death among cancer survivors with type 2 diabetes in Taiwan.
    Hsieh HM; Chiu HC; Lin YT; Shin SJ
    Int J Qual Health Care; 2017 Aug; 29(4):512-520. PubMed ID: 28531317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Diabetes Pay-for-Performance Program and Risks of Cancer Incidence and Death in Patients With Type 2 Diabetes in Taiwan.
    Hsieh HM; He JS; Shin SJ; Chiu HC; Lee CT
    Prev Chronic Dis; 2017 Oct; 14():E88. PubMed ID: 28981404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of pay-for-performance program on infection events and mortality rate in diabetic patients: a nationwide population-based cohort study.
    Wu YF; Chen MY; Chen TH; Wang PC; Peng YS; Lin MS
    BMC Health Serv Res; 2021 Jan; 21(1):78. PubMed ID: 33478477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between participation in a pay-for-performance program and macrovascular complications in patients with type 2 diabetes in Taiwan: A nationwide population-based cohort study.
    Hsieh HM; Lin TH; Lee IC; Huang CJ; Shin SJ; Chiu HC
    Prev Med; 2016 Apr; 85():53-59. PubMed ID: 26740347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adding Pay-for-Performance Program to Routine Care Was Related to a Lower Risk of Depression Among Type 2 Diabetes Patients in Taiwan.
    Lian WC; Livneh H; Huang HJ; Lu MC; Guo HR; Tsai TY
    Front Public Health; 2021; 9():650452. PubMed ID: 34722429
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of a Pay-for-Performance Program on Renal Outcomes Among Patients With Early-Stage Chronic Kidney Disease in Taiwan.
    Lin MT; Hsu CN; Lee CT; Cheng SH
    Int J Health Policy Manag; 2022 Aug; 11(8):1307-1315. PubMed ID: 33906336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is a diabetes pay-for-performance program cost-effective under the National Health Insurance in Taiwan?
    Tan EC; Pwu RF; Chen DR; Yang MC
    Qual Life Res; 2014 Mar; 23(2):687-96. PubMed ID: 23975377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the relationship between a chronic disease care management program and california pay-for-performance diabetes care cholesterol measures in one medical group.
    Cutler TW; Palmieri J; Khalsa M; Stebbins M
    J Manag Care Pharm; 2007 Sep; 13(7):578-88. PubMed ID: 17874864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pay-for-performance programmes reduce stroke risks in patients with type 2 diabetes: a national cohort study.
    Chou CW; Kung PT; Chou WY; Tsai WC
    BMJ Open; 2019 Oct; 9(10):e026626. PubMed ID: 31619415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of pay for performance on risk incidence of hip fracture in type 2 diabetic patients: a nationwide population-based cohort study.
    Lee YH; Kung PT; Kuo WY; Kao SL; Tsai WC
    Medicine (Baltimore); 2020 Mar; 99(12):e19592. PubMed ID: 32195973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects and Factors Related to Adherence to A Diabetes Pay-for-Performance Program: Analyses of a National Health Insurance Claims Database.
    Chi MJ; Chou KR; Pei D; Hwang JS; Quinn L; Chung MH; Liao YM
    J Am Med Dir Assoc; 2016 Jul; 17(7):613-9. PubMed ID: 27073041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors related to continuing care and interruption of P4P program participation in patients with diabetes.
    Yen SM; Kung PT; Sheen YJ; Chiu LT; Xu XC; Tsai WC
    Am J Manag Care; 2016 Jan; 22(1):e18-30. PubMed ID: 26799201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pay-for-performance for shared care of diabetes in Taiwan.
    Lee IT; Hsu CC; Sheu WH; Su SL; Wu YL; Lin SY
    J Formos Med Assoc; 2019 Nov; 118 Suppl 2():S122-S129. PubMed ID: 31471222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the pay-for-performance programme reduce the emergency department visits for hypoglycaemia in type 2 diabetic patients?
    Yu HC; Tsai WC; Kung PT
    Health Policy Plan; 2014 Sep; 29(6):732-41. PubMed ID: 23894069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of a pay for performance program on diabetes care in Taiwan: A nationwide population-based longitudinal study.
    Lin TY; Chen CY; Huang YT; Ting MK; Huang JC; Hsu KH
    Health Policy; 2016 Nov; 120(11):1313-1321. PubMed ID: 27780591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pay-for-performance and continuity of care synergistically reduced amputation of lower extremity in patients with diabetes: a population-based cohort study.
    Chen YC; Liao YH; Ku LE; Wang JD
    BMC Health Serv Res; 2022 Jun; 22(1):748. PubMed ID: 35659668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Body Mass Index and Pay-for-Performance Program on Risk of Death in Patients with Type 2 Diabetes: A Nationwide Cohort Study.
    Huang HL; Kung CY; Wang SM; Kung PT; Lin YH; Chiu LT; Tsai WC
    Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33925667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Nationwide COPD Pay-for-Performance Program on COPD Exacerbations in Taiwan.
    Cheng SL; Li YR; Huang N; Yu CJ; Wang HC; Lin MC; Chiu KC; Hsu WH; Chen CZ; Sheu CC; Perng DW; Lin SH; Yang TM; Lin CB; Kor CT; Lin CH
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2869-2881. PubMed ID: 34703221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.